Janssen Pharmaceuticals, Inc. v. Mylan Laboratories Limited
Plaintiff / Appellee: JANSSEN PHARMACEUTICALS, INC. and JANSSEN PHARMACEUTICA NV
Defendant / Appellant: MYLAN LABORATORIES LIMITED
Case Number: 22-1307
Filed: December 28, 2021
Court: U.S. Court of Appeals, Federal Circuit
Nature of Suit: Patent - (ANDA) (Fed. Question)
Docket Report

This docket was last retrieved on January 11, 2022. A more recent docket listing may be available from PACER.

Date Filed Document Text
January 11, 2022 Filing 6 Note to File: The following cases are consolidated: 22-1258 Lead with 22-1307 Member Case. The parties must file all documents in the lead appeal only. [823949] [22-1258, 22-1307] [JCW] [Entered: 01/11/2022 04:31 PM]
January 11, 2022 Opinion or Order Filing 5 ORDER consolidating appeals (22-1258, 22-1307). Appellants' opening briefs are due no later than February 28, 2022. Service as of this date by the Clerk of Court. [823946] [22-1258, 22-1307] [JCW] [Entered: 01/11/2022 04:30 PM]
January 10, 2022 Filing 4 Certificate of Interest for Appellees Janssen Pharmaceutica NV and Janssen Pharmaceuticals, Inc.. Service: 01/10/2022 by email. [823578] [22-1307] [Barbara Mullin] [Entered: 01/10/2022 03:08 PM]
January 10, 2022 Filing 3 Docketing Statement for the Appellees Janssen Pharmaceutica NV and Janssen Pharmaceuticals, Inc.. Service: 01/10/2022 by email. [823576] [22-1307] [Barbara Mullin] [Entered: 01/10/2022 03:06 PM]
January 10, 2022 Filing 2 Entry of appearance for Barbara L. Mullin; Andrew D. Cohen as counsel for Appellees Janssen Pharmaceutica NV and Janssen Pharmaceuticals, Inc.. Service: 01/10/2022 by email. [823572] [22-1307] [Barbara Mullin] [Entered: 01/10/2022 03:03 PM]
December 28, 2021 Filing 1 Appeal docketed. Received: 12/27/2021. [821502] Entry of Appearance is due on 01/11/2022. Certificate of Interest is due on 01/11/2022. Docketing Statement is due on 01/11/2022. Appellant's brief is due on 02/28/2022. [EKD] [Entered: 12/28/2021 11:10 AM]

Access additional case information on PACER

Access the Case Summary and Docket Report to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.

Search for this case: Janssen Pharmaceuticals, Inc. v. Mylan Laboratories Limited
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Web [ Unicourt | Legal Web | Google | Bing | Yahoo | Ask ]
Plaintiff / appellee: JANSSEN PHARMACEUTICALS, INC.
Represented By: Zhiqiang Liu
Represented By: Barbara Mullin
Represented By: Andrew D. Cohen Esq.
Represented By: Aron Russell Fischer
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Plaintiff / appellee: JANSSEN PHARMACEUTICA NV
Represented By: Zhiqiang Liu
Represented By: Barbara Mullin
Represented By: Andrew D. Cohen Esq.
Represented By: Aron Russell Fischer
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Defendant / appellant: MYLAN LABORATORIES LIMITED
Represented By: Arnold B. Calmann
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]

Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.


Why Is My Information Online?